E. Hasrouni

发表

Notch mediated patterning and cell fate allocation of pancreatic progenitor cells

J. Jensen, Solomon Afelik, M. A. Bukys, 2011 .

Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes.

S. Shetty, A. Advani, M. Sekeres, 2015, Clinical lymphoma, myeloma & leukemia.

A case of mistaken identity: When lupus masquerades as primary myelofibrosis

J. Maciejewski, M. Sekeres, F. Traina, 2013, SAGE open medical case reports.

Notch-mediated patterning and cell fate allocation of pancreatic progenitor cells

J. Jensen, Raymond J MacDonald, Tye G. Deering, 2012, Development.

SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype

C. O'keefe, M. Sekeres, H. Makishima, 2013, Haematologica.

Running Title: SF3B1 and non-MDS and mast cell disease

C. O'keefe, M. Sekeres, H. Makishima, 2013 .

A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN

Y. Saunthararajah, M. Sekeres, F. Traina, 2012 .

Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine

Y. Saunthararajah, M. Sekeres, M. Kalaycio, 2014, Leukemia & lymphoma.

Impact of allogeneic hematopoietic stem cell transplant (HSCT) on patients harboring the spliceosome mutation SRSF2.

M. Sekeres, M. Kalaycio, P. Elson, 2013 .

Impact of Mutations in the Spliceosome Machinery and Ring Sideroblasts in Patients with Myeloid Malignancies Who Received Conventional Chemotherapy or Allogeneic Hematopoietic Cell Transplantation

J. Maciejewski, M. Sekeres, M. Kalaycio, 2012 .

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

J. Barnard, A. Heuer, Y. Saunthararajah, 2014, Leukemia.

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

A. Jankowska, C. O'keefe, J. Maciejewski, 2014, Leukemia.

Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations

J. Maciejewski, M. Sekeres, M. Kalaycio, 2016, American journal of hematology.

Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts

J. Barnard, Y. Saunthararajah, R. Mahfouz, 2014, Journal of Hematology & Oncology.

Splicing Factor 3b Subunit 1 (SF3B1) mediates Mitochondrial Iron Overload In Myelodysplastic Syndromes With Ring Sideroblasts By Alternative Splicing Of Mitoferrin-1 (SLC25A37)

J. Barnard, A. Heuer, Y. Saunthararajah, 2013 .

BCL-2 Family Of Genes Is a Key Regulator In The Pathogenesis Of SF3B1 Mutant and Wild Type MDS With Ring Sideroblasts and Represents a Novel Drug Target In This Disease

J. Barnard, Y. Saunthararajah, R. Mahfouz, 2013 .